T1	Participants 849 985	Patients aged 25 to 74 years attending community pharmacies with a prescription for at least 1 drug indicated for CVD or CV risk factors
T2	Participants 108 170	outpatients with cardiovascular disease or cardiovascular risk
T3	Participants 729 839	patients with CVD and/or high or intermediate cardiovascular (CV) risk attending community pharmacies in Spain
T4	Participants 3203 3296	patients with CVD and/or high or intermediate CV risk attending community pharmacies in Spain
T5	Participants 518 535	patients with CVD
